Should You Buy Ardent Health, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Ardent Health, Inc. (ARDT) ranks in the top tier of our coverage universe with a Quality of Company score of 9.1/10. Trading at a market price of $10.16, this high-quality profile requires careful comparison against our 13 intrinsic value models.
The short answer: 7 of 11 CirclFi valuation models project upside for Ardent Health, Inc. (ARDT) at $10.16 — the model consensus leans bullish, with a Quality Score of 9.1/10 and Value-Trap risk of —/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
Investment Thesis
The Bull Case
Target: $26.89 (+164.6% upside)
- According to the CirclFi Quality of Company (QOC) framework, Ardent Health, Inc.'s quality score of 9.1/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation.
- According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $10.16 and the composite fair value of $14.08 implies +38.6% upside potential.
- According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $26.89 (+164.6%), anchoring the bull case with a methodology that provides a differentiated analytical lens.
The Bear Case
Target: $1.18 (-88.4%)
- According to the CirclFi Deep Alpha Valuation Engine, the Sentiment SOTP model sees the stock as overvalued with a fair value of $1.18 (-88.4%), suggesting that the market price embeds overly optimistic growth assumptions.
- According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +253.1% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.
The Bottom Line
The balance of evidence tilts cautiously positive for Ardent Health, Inc. at $10.16. 7 of 11 models support upside to $14.08, backed by a 9.1/10 quality foundation. This is a "lean into, not load up on" setup in our framework.
These are quantitative model outputs, not investment recommendations. Ardent Health, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
Frequently Asked Questions
Should I buy ARDT stock right now?
Based on CirclFi's multi-model analysis, 7 of 11 models see upside for ARDT at $10.16. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 9.1/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Ardent Health, Inc.?
Key risks include: wide model disagreement (2185% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.
How does ARDT compare to its competitors?
Among Medical Care Facilities peers, ARDT holds a Quality Score of 9.1/10. Comparable companies include ADUS (QOC 9.7), ENSG (QOC 9.3), PNTG (QOC 9.3). The relative ranking helps investors identify whether ARDT offers better fundamental quality than alternatives in the same sector.
Is ARDT a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ARDT's Quality Score of 9.1/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy ARDT at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $1.18 to $26.89. At $10.16, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for ARDT.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad